We still have the major issue (IMO) of cell specificity. To date that is why we s tr e limeted to the eye i believe. We couldn't even progress a treatment for blood bourne cancers and that would have been a way larger potential market. Just sayin while i love your enthusiasm the only platform we seem to have is within the eye or any other isolated area we can discover in the near future. Did anyone get any detail on weather cell specificity was advancing or was a concern from recent meetings? I think we certainly have a feasible target now with the eye drug but still aways off a platform that can access or cure anything anyone might ask for. if it stays that way then we may still see gains but not in the billion mc area i suspect.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)